Literature for avoralstat (S01.212 inhibitor)

(Topics flags: I Inhibitor. To select only the references relevant to a single topic, click the link above. See explanation.)

2018
1. Riedl,M.A., Aygoren-Pursun,E., Baker,J., Farkas,H., Anderson,J., Bernstein,J.A., Bouillet,L., Busse,P., Manning,M., Magerl,M., Gompels,M., Huissoon,A.P., Longhurst,H., Lumry,W., Ritchie,B., Shapiro,R., Soteres,D., Banerji,A., Cancian,M., Johnston,D.T., Craig,T.J., Launay,D., Li,H.H., Liebhaber,M., Nickel,T., Offenberger,J., Rae,W., Schrijvers,R., Triggiani,M., Wedner,H.J., Dobo,S., Cornpropst,M., Clemons,D., Fang,L., Collis,P., Sheridan,W.P. and Maurer,M.
   Evaluation of avoralstat, an oral kallikrein inhibitor, in a phase 3 hereditary angioedema prophylaxis trial: the OPUS-2 study
   Allergy73, 1871-1880. PubMed  Europe PubMed DOI  I
2016
2. Cornpropst,M., Collis,P., Collier,J., Babu,Y.S., Wilson,R., Zhang,J., Fang,L., Zong,J. and Sheridan,W.P.
   Safety, pharmacokinetics, and pharmacodynamics of avoralstat, an oral plasma kallikrein inhibitor: phase 1 study
   Allergy71, 1676-1683. PubMed  Europe PubMed DOI  I
2006
3. Zhang,J., Krishnan,R., Arnold,C.S., Mattsson,E., Kilpatrick,J.M., Bantia,S., Dehghani,A., Boudreaux,B., Gupta,S.N., Kotian,P.L., Chand,P. and Babu,Y.S.
   Discovery of highly potent small molecule kallikrein inhibitors
   Med Chem2, 545-553. PubMed  Europe PubMed  I